[1]
Yashchenko, M. 2021. Risks of using pre-event time scale and ordinal scale measurements in COVID-19 clinical trials. Infusion & Chemotherapy. 4 (Dec. 2021), 32-37. DOI:https://doi.org/10.32902/2663-0338-2021-4-32-37.